Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Signaling

Background:

• Wnt5a, a non-canonical Wnt ligand, exhibits context-dependent roles in neoplasms.
• Previous studies indicate increased Wnt5a expression and Ryk-mediated invasion in glioblastomas.

Purpose of the Study:

• To investigate the expression of Wnt5a, its receptors Ryk and Ror2, and β-catenin in glioblastoma.
• To analyze associations with clinicopathological/molecular variables and prognosis.

Main Methods:

• Protein expression analysis of Wnt5a, Ryk, Ror2, and β-catenin in 186 glioblastoma cases.
• Statistical analysis of correlations with clinicopathological and molecular data.
• Prognostic impact assessment.

Main Results:

• Wnt5a, Ryk, and Ror2 were expressed in all glioblastoma cases.
• Ryk and Ror2 expression correlated with Wnt5a expression.
• No prognostic impact of Wnt5a, Ryk, or Ror2 was observed; β-catenin correlated with shorter progression-free survival in the GBMO subgroup.

Conclusions:

• Findings support Ryk-mediated Wnt5a effects in glioblastoma.
• Suggests a potential role for Ror2 in Wnt5a signaling pathways within glioblastoma.